Bregua Corp - Jun 15, 2021 Form 4 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
10%+ Owner
Signature
/s/ Klaus Dorner, Director of Bregua Corporation
Stock symbol
JANX
Transactions as of
Jun 15, 2021
Transactions value $
$999,991
Form type
4
Date filed
6/16/2021, 06:22 PM
Previous filing
Jun 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JANX Common Stock Conversion of derivative security +1.14M 1.14M Jun 15, 2021 Direct F1, F2
transaction JANX Common Stock Conversion of derivative security +1.63M +143.19% 2.77M Jun 15, 2021 Direct F1, F2
transaction JANX Common Stock Conversion of derivative security +674K +24.35% 3.44M Jun 15, 2021 Direct F1, F2
transaction JANX Common Stock Conversion of derivative security +247K +7.18% 3.69M Jun 15, 2021 Direct F1, F2
transaction JANX Common Stock Purchase $1M +58.8K +1.59% $17.00 3.75M Jun 15, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JANX Series Seed Convertible Preferred Stock Conversion of derivative security -889K -100% 0 Jun 15, 2021 Common Stock 1.14M Direct F1, F2
transaction JANX Series Seed 2 Convertible Preferred Stock Conversion of derivative security -1.27M -100% 0 Jun 15, 2021 Common Stock 1.63M Direct F1, F2
transaction JANX Series A Convertible Preferred Stock Conversion of derivative security -526K -100% 0 Jun 15, 2021 Common Stock 674K Direct F1, F2
transaction JANX Series B Convertible Preferred Stock Conversion of derivative security -193K -100% 0 Jun 15, 2021 Common Stock 247K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Bregua Corp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each share of Series Seed Convertible Preferred Stock, Series Seed 2 Convertible Preferred Stock, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") converted into 1.281 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
F2 These securities are held directly by Bregua Corporation (Bregua). Klaus Dorner is the Director of Bregua and may be deemed to have voting and investment power with respect to the shares held by Bregua and as a result may be deemed to have beneficial ownership of such shares. Mr. Dorner disclaims beneficial ownership of all shares held by Bregua, except to the extent of his actual pecuniary interest therein, if any.
F3 The shares were purchased in the Issuer's initial public offering.